BIT
NVAX icon

BlackRock Institutional Trust’s Novavax NVAX Stock Holding History

BlackRock Institutional Trust’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$9.59M Buy
380,676
+45,208
+13% +$1.32M ﹤0.01% 2429
2016
Q3 		$14M Buy
335,468
+8,190
+3% +$1.06M ﹤0.01% 2128
2016
Q2 		$47.6M Sell
327,278
-2,090
-0.6% -$240K 0.01% 1262
2016
Q1 		$34M Sell
329,368
-130
-0% -$13.9K 0.01% 1467
2015
Q4 		$55.3M Sell
329,498
-9,395
-3% -$1.45M 0.01% 1179
2015
Q3 		$47.9M Buy
338,893
+18,719
+6% +$4.2M 0.01% 1248
2015
Q2 		$71.3M Sell
320,174
-4,317
-1% -$759K 0.01% 1102
2015
Q1 		$53.7M Sell
324,491
-1,128
-0.3% -$183K 0.01% 1276
2014
Q4 		$38.6M Sell
325,619
-6,895
-2% -$721K 0.01% 1462
2014
Q3 		$27.7M Buy
332,514
+16,011
+5% +$1.45M ﹤0.01% 1664
2014
Q2 		$29.2M Buy
316,503
+33,459
+12% +$2.94M ﹤0.01% 1696
2014
Q1 		$25.6M Buy
283,044
+20,723
+8% +$2.32M ﹤0.01% 1795
2013
Q4 		$26.9M Buy
262,321
+46,064
+21% +$3.25M ﹤0.01% 1724
2013
Q3 		$13.6M Sell
216,257
-3,317
-2% -$187K ﹤0.01% 2134
2013
Q2 		$9M Buy
+219,574
New +$9.51M ﹤0.01% 2379

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $917M AUM 3.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Institutional Trust's NVAX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Novavax (NVAX) stake by 13% in Q4 2016, buying an estimated $1.32M and bringing the position to 380,676 shares worth $9.59M. The position accounts for ﹤0.01% of the portfolio, ranked #2429.

BlackRock Institutional Trust first reported a position in NVAX in Q2 2013 and has held it in 15 quarters since. The position peaked at $71.3M in Q2 2015. 143 funds tracked by Wall St. Rank hold NVAX as of Q4 2016.

  • BlackRock Institutional Trust held 380,676 shares of Novavax worth $9.59M as of Q4 2016.
  • BlackRock Institutional Trust bought 45,208 Novavax shares in Q4 2016, an estimated $1.32M.
  • Novavax made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2429 holding.
  • BlackRock Institutional Trust first reported a position in Novavax in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Novavax position peaked at $71.3M in Q2 2015.
  • 143 funds tracked by Wall St. Rank held Novavax as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.